ORIC PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • January 22nd, 2024 • Oric Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2024 Company Industry JurisdictionThis Stock Purchase Agreement (the “Agreement”) is made as of January 20, 2024 (the “Effective Date”), by and among ORIC Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
OLEMA PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 5th, 2023 • Olema Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 5th, 2023 Company Industry JurisdictionThis Stock Purchase Agreement (the “Agreement”) is made as of September 5, 2023 (the “Effective Date”), by and among Olema Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
GOSSAMER BIO, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 13th, 2022 • Gossamer Bio, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 13th, 2022 Company Industry JurisdictionThis Stock Purchase Agreement (the “Agreement”) is made as of July 12, 2022 (the “Effective Date”), by and among Gossamer Bio, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
CRINETICS PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 29th, 2021 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2021 Company Industry JurisdictionThis Stock Purchase Agreement (the “Agreement”) is made as of July 28, 2021 (the “Effective Date”), by and among Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
KRYSTAL BIOTECH, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 17th, 2018 • Krystal Biotech, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 17th, 2018 Company Industry JurisdictionThis Stock Purchase Agreement (the “Agreement”) is made as of August 16, 2018 (the “Effective Date”), by and among Krystal Biotech, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).